A83934f6 3c1d 42b6 A5e1 3b8f83fce553 01
Bumetanide Tablet
Product Images NDC 68382-526
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 68382-526). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
A83934f6 3c1d 42b6 A5e1 3b8f83fce553 02
A83934f6 3c1d 42b6 A5e1 3b8f83fce553 03
This is the label of a medication, which contains bumetanide. Each tablet contains 1mg of bumetanide USP. The usual dosage is provided in the package insert. The tablets should be stored at controlled room temperature in a light-resistant container. It is recommended to keep the container tightly closed and to store it out of the reach of children. The product is manufactured by Cadila Healthcare Ltd. in India and distributed by Zydus Pharmaceuticals in the USA.*
A83934f6 3c1d 42b6 A5e1 3b8f83fce553 04
This is a label for a medication called Bumetanide, which comes in tablet form. The label includes important information such as the expiration date, dosage instructions, and storage requirements. The medication is manufactured in Italy and distributed by Zydus Pharmaceuticals in the United States. The label also includes a warning to keep the medication tightly closed and out of the reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
